Medicare was cleared to negotiate drug prices for the first time by the Senate’s top rules official, though the Democrats’ proposal intended to cap price increases for prescription drugs in the commercial market was blocked.
The ruling will allow drug makers, to try to make up their lost profits in Medicare on private insurers . . .
actually patients of course‼️